Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Capital/Financing Update 2025

Nov 18, 2025

30528_rns_2025-11-18_d743da54-d544-4206-8859-49e69d0d5dce.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [128 x 29] intentionally omitted <==

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India

CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: [email protected] Web: www.drreddys.com

November 18, 2025

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY) BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

This is to inform that the Company’s management will be participating in the following investor conference with single institution(s)/ investor groups:

Date Organized by Location Meeting mode Nature of meet Timing
21.11.2025 Investec Mumbai In - Person Group Meet 09:00 - 13:00 IST
26.11.2025 Citi Hyderabad In – Person Group Meet 14:30 - 15:30 IST
27.11.2025 HSBC Hong Kong In – Person Group Meet 12:30 – 18:00 HKT
28.11.2025 HSBC Hong Kong In – Person Group Meet 09:00 – 18:00 HKT

Please note that the schedule of the aforesaid meeting is subject to change due to any exigencies on the part of Investors / Company.

This is for your information.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

KUMAR Digitally signed by KUMAR RANDHIR RANDHIR SINGH Date: 2025.11.18 SINGH 19:26:57 +05'30'

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR